HK1067129A1 - A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds - Google Patents

A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds

Info

Publication number
HK1067129A1
HK1067129A1 HK05100509.9A HK05100509A HK1067129A1 HK 1067129 A1 HK1067129 A1 HK 1067129A1 HK 05100509 A HK05100509 A HK 05100509A HK 1067129 A1 HK1067129 A1 HK 1067129A1
Authority
HK
Hong Kong
Prior art keywords
compounds
analgous
perindopril
dioxo
salts
Prior art date
Application number
HK05100509.9A
Other languages
English (en)
Inventor
Pau Cid
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8183486&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1067129(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adir filed Critical Adir
Publication of HK1067129A1 publication Critical patent/HK1067129A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
HK05100509.9A 2001-07-24 2005-01-19 A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds HK1067129A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01500197 2001-07-24
PCT/EP2002/008223 WO2003010142A2 (fr) 2001-07-24 2002-07-23 Procede

Publications (1)

Publication Number Publication Date
HK1067129A1 true HK1067129A1 (en) 2005-04-01

Family

ID=8183486

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05100509.9A HK1067129A1 (en) 2001-07-24 2005-01-19 A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds

Country Status (24)

Country Link
US (1) US20040248814A1 (fr)
EP (1) EP1279665B1 (fr)
JP (1) JP4083118B2 (fr)
KR (1) KR100694528B1 (fr)
CN (1) CN100503568C (fr)
AR (1) AR036187A1 (fr)
AT (1) ATE386717T1 (fr)
AU (1) AU2002328954B2 (fr)
BR (1) BR0211422A (fr)
CY (1) CY1107403T1 (fr)
DE (1) DE60225092T2 (fr)
DK (1) DK1279665T3 (fr)
EA (1) EA007000B1 (fr)
ES (1) ES2300402T3 (fr)
HK (1) HK1067129A1 (fr)
HU (1) HUP0202414A3 (fr)
MX (1) MXPA04000649A (fr)
NO (1) NO20040278L (fr)
NZ (1) NZ530578A (fr)
PL (1) PL355161A1 (fr)
PT (1) PT1279665E (fr)
SI (1) SI1279665T1 (fr)
WO (1) WO2003010142A2 (fr)
ZA (1) ZA200400323B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2289060T3 (es) 2002-01-30 2008-02-01 Les Laboratoires Servier Proceso para la preparacion de perindopril de alta pureza y de intermedios utiles en su sintesis.
DK1603558T3 (da) 2003-02-28 2008-09-01 Servier S A Lab Fremgangsmåde til fremstilling af perindopril og salte deraf
ES2386161T3 (es) 2003-04-16 2012-08-10 Bristol-Myers Squibb Company Proceso para separar una mezcla de enantiómeros de éster alquílico usando una enzima
SI21506A (sl) * 2003-05-08 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo perindoprila
SI21507A (sl) 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
AU2003263584A1 (en) * 2003-08-21 2005-03-10 Hetero Drugs Limited Process for pure perindopril tert-butylamine salt
JP4677611B2 (ja) * 2003-10-21 2011-04-27 レ ラボラトワール セルヴィエ 結晶ペリンドプリルエルブミンの新規な調製方法
SI21703A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
ES2255872B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la preparacion de perindopril erbumina.
US7291745B2 (en) 2005-03-21 2007-11-06 Glenmark Pharmaceuticals Limited Process for the preparation of perindopril
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2006137082A1 (fr) * 2005-06-23 2006-12-28 Ramesh Babu Potluri Procédé pour la préparation de périndopril erbumine viable industriellement
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
EP2044010B1 (fr) 2006-05-12 2014-01-08 EGIS Gyógyszergyár Nyilvánosan Müködõ Részvénytársaság Nouveaux intermédiaires pharmaceutiques dans la synthèse d'inhibiteurs de l'enzyme de conversion d'angiotensine (ace) et utilisation de ceux-ci
JP2008019214A (ja) * 2006-07-13 2008-01-31 Shiono Chemical Co Ltd ペリンドプリルまたはその誘導体の製造方法
CN101679295A (zh) 2007-06-06 2010-03-24 帝斯曼知识产权资产管理有限公司 新颖的被5-取代的乙内酰脲
FR2985512B1 (fr) * 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
CN111116709B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种培哚普利制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487829A2 (fr) * 1979-12-07 1982-02-05 Science Union & Cie Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
EP0050800B2 (fr) * 1980-10-23 1995-06-07 Schering Corporation Dipeptides carboxyalcoyliques, procédés pour les préparer et compositions pharmaceutiques les contenant
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
US4496542A (en) 1981-03-30 1985-01-29 Usv Pharmaceutical Corporation N-substituted-amido-amino acids
US4558038A (en) 1981-03-30 1985-12-10 Usv Pharmaceutical Corp. N-Substituted-amindo-amino acids
US4686295A (en) * 1982-03-10 1987-08-11 Usv Pharmaceutical Corporation N-carboxy anhydride intermediates
US4885293A (en) * 1984-09-24 1989-12-05 Schering Corporation Antiglaucoma agents
JPS6248696A (ja) 1985-08-27 1987-03-03 Kanegafuchi Chem Ind Co Ltd Ｎ−〔１（ｓ）−エトキシカルボニル−３−フエニルプロピル〕−ｌ−アラニル−ｌ−プロリンの製造法
ES2004804A6 (es) * 1987-08-13 1989-02-01 Pharma Investi S A Un procedimiento para preparar derivados de carboxialquildipeptidos
FR2620703B1 (fr) * 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
FR2620700B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2620699B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et de leurs esters. application a la synthese de carboxyalkyl dipeptides
US5258525A (en) * 1991-03-27 1993-11-02 Mcneilab, Inc. Processes for preparing [2S-(2α,3aβ,7aβ)]octahydro-1H-indole-2-carboxylic acid and esters
SI9200213A (en) * 1992-09-16 1994-03-31 Krka Process for preparing alkyl-l-alanil-l-proline derivates
IN184759B (fr) 1997-07-22 2000-09-23 Kaneka Corp
SE0000382D0 (sv) * 2000-02-07 2000-02-07 Astrazeneca Ab New process

Also Published As

Publication number Publication date
KR100694528B1 (ko) 2007-03-13
AR036187A1 (es) 2004-08-18
HU0202414D0 (fr) 2002-09-28
PL355161A1 (en) 2003-01-13
NZ530578A (en) 2007-02-23
WO2003010142A3 (fr) 2003-08-28
BR0211422A (pt) 2004-08-17
ZA200400323B (en) 2005-03-30
EP1279665B1 (fr) 2008-02-20
AU2002328954B2 (en) 2007-10-04
CY1107403T1 (el) 2012-12-19
ATE386717T1 (de) 2008-03-15
SI1279665T1 (sl) 2008-06-30
NO20040278L (no) 2004-01-21
MXPA04000649A (es) 2004-10-27
KR20040029378A (ko) 2004-04-06
US20040248814A1 (en) 2004-12-09
DK1279665T3 (da) 2008-06-23
DE60225092D1 (de) 2008-04-03
EP1279665A2 (fr) 2003-01-29
HUP0202414A3 (en) 2003-05-28
DE60225092T2 (de) 2009-02-19
PT1279665E (pt) 2008-03-28
EA007000B1 (ru) 2006-06-30
ES2300402T3 (es) 2008-06-16
EP1279665A3 (fr) 2003-03-12
WO2003010142A2 (fr) 2003-02-06
CN100503568C (zh) 2009-06-24
HUP0202414A2 (hu) 2003-02-28
JP2005501829A (ja) 2005-01-20
JP4083118B2 (ja) 2008-04-30
CN1529694A (zh) 2004-09-15
EA200400129A1 (ru) 2004-08-26

Similar Documents

Publication Publication Date Title
HK1067129A1 (en) A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds
IL157478A0 (en) Method for the synthesis of 2', 3'-didehydronucleosides
IL143477A0 (en) A NEW PROCESS FOR THE PREPARATION OF 17-PHENYL-18,19,20-TRINOR-PGF2α AND ITS DERIVATIVES
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
ZA200203252B (en) Process for preparing 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycina derivatives.
HUP0402027A3 (en) Process for the preparation of a xantophyll
HRP20040161A2 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
IL157709A0 (en) Process for the preparation of 1,2-benzisoxazole-3-acetic acid
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
AU2002330042A1 (en) Process for the preparation of 1,5-diarylpyrazoles
IL162188A0 (en) Process for the preparation of Ä1,4,5Ü-oxadiazepine derivatives
HUP0401577A3 (en) Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses
HK1048112A1 (en) Process for the preparation of a 3-vinylcephem compound.
IL144066A0 (en) Process for the preparation of 1,1-cyclohexane diacetic monoamide
AU2002310898A1 (en) Process for the preparation of a polymer-amine
AU6870600A (en) Process for the preparation of 2,3-dihydroazepine compounds
HUP0401989A3 (en) A process for the preparation of the 14 beta-hydroxy-baccatin iii-1,14-carbonate
HUP0200187A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
EP1295864A4 (fr) Procede de preparation de 1,5-diaminonaphtalenes
IL162770A (en) Process for the preparation of 7??-methyl-estr-4-ene-3-one derivatives
IL137364A0 (en) A process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
AU2002311623A1 (en) Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents
HUP0402020A3 (en) A process for preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
AU2001282067A1 (en) Process for the preparation of chiral 1,4-diaryl-2-fluoro-2-butenes
HK1041606B (zh) N，n'-羰基雙內酰胺的製備方法